Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 323 (113th)

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013

referredUnited States· United States Congress· EN

Introduced

13 February 2013

Last action

13 February 2013 · Introduced

Status

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S715)

Sponsors

Sen. Durbin, Richard J. [D-IL], Sen. Cochran, Thad [R-MS], Sen. Blumenthal, Richard [D-CT], Sen. Tester, Jon [D-MT], Sen. Landrieu, Mary L. [D-LA], Sen. Harkin, Tom [D-IA], Sen. Udall, Tom [D-NM], Sen. Wicker, Roger F. [R-MS], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Whitehouse, Sheldon [D-RI], Sen. Hagan, Kay R. [D-NC], Sen. Blunt, Roy [R-MO], Sen. King, Angus S., Jr. [I-ME], Sen. Warren, Elizabeth [D-MA], Sen. Shaheen, Jeanne [D-NH], Sen. Schumer, Charles E. [D-NY], Sen. Boxer, Barbara [D-CA], Sen. Menendez, Robert [D-NJ], Sen. Brown, Sherrod [D-OH]

Subjects

Healthcare

Source updated

6 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 - Amends title II (Old Age, Survivors and Disability Benefits) (OASDI) of the Social Security Act (SSA) to extend the months of coverage of immunosuppressive drugs for kidney transplant patients. Amends SSA title XVIII (Medicare) to make eligible for enrollment in Medicare part B (Supplementary Medical Insurance), solely for the purpose of such drug coverage, every individual whose insurance benefits under Medicare part A (Hospital Insurance) have ended by reason of a kidney transplant or the end of any requirement for a regular course of dialysis. Directs the Secretary of Health and Human Services (HHS) to determine a monthly premium rate for such individuals equal to 35% of the monthly actuarial rate for enrollees age 65 and over. Prescribes a formula for detemination of a government contribution to such a premium.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 February 2013

    Introduced

    Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S715)

    Source: IntroReferral

  2. 13 February 2013

    Introduced

    Sponsor introductory remarks on measure. (CR S714)

    Source: IntroReferral

  3. 13 February 2013

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 13 February 2013

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 13 February 2013

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 13 February 2013

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.